Proteome analysis in breast cancer cells reveals differential expression of signatures involved in premRNA alternative splicing events in response to 17b-estradiol and CRH
that 70% of breast cancers are estrogen receptor-positive (ER+) and activation of cellular processes involved in several tumorigenesis-associated events are detected predominantly in ER+ breast cancer. To characterize…

